FDA Approves New Hydrocodone Painkiller
The U.S. Food and Drug Administration has approved a new extended release version of hydrocodone – an opioid pain reliever that will be the first…
Zogenix
Express Scripts Excludes Zohydro from Coverage
Express Scripts, the nation’s largest national Pharmacy Benefit Management Service (PBMS), has dropped Zohydro ER from its 2015 formulary of covered medications. Insured patients whose…
Zogenix: No Overdoses or Diversion Caused by Zohydro
Six months after the introduction of Zohydro, there have been no confirmed cases of diversion, overdose or death caused by the controversial painkiller, according to…
Zohydro Sales Growing
Sales of Zohydro – a controversial new hydrocodone painkiller – are growing steadily, despite efforts in some states to ban or restrict the prescribing of…
FDA Gives ‘Priority Review’ to New Hydrocodone Painkiller
The race to be the first drug maker to get approval for a hydrocodone painkiller with an abuse-deterrent formula continues to heat up. Purdue Pharma…
FDA Commissioner: Zohydro Won’t Increase Drug Abuse
A controversial new painkiller is no more powerful or addictive than other opioid medications already on the market and pain patients should have access to…
Judge Overturns Massachusetts Ban on Zohydro
A federal judge in Boston has ruled that an unprecedented ban on the sale of a controversial new painkiller in Massachusetts is unconstitutional. Despite the…
Federal Judge Asked to Lift Ban on Zohydro
An unprecedented ban on a controversial new painkiller remains in effect in Massachusetts, after a federal judge in Boston heard arguments in a lawsuit by…